Lindus Health RAISES $55M in SERIES B FUNDING.
Therapeutic Area:
HPV
Description:
  • 375 participant study
  • HPV Diagnostic
Results:
3 weeks
to enroll 375 participants
Therapeutic Area:
Infectious disease
Description:
  • At-home testing for STDs
  • Screening, ePRO and remote testing
Results:
<1 month
Completed recruitment
Therapeutic Area:
Mental Health
Description:
  • Drug trial
  • 30 adults with previously treated depression
Results:
>200
Leads shared in <1 month
Therapeutic Area:
Neurodivergence
Description:
  • 4000 Participants
  • Nationwide participation
Results:
10,000+

Prescreened in under 3 months

Therapeutic Area:
Ophthalmology-Myopia
Description:
  • Pivotal registration trial
  • Community site based study
Results:
1 week
database lock thanks to Citrus™  CDISC download
Therapeutic Area:
Pre-diabetes
Description:
  • EFSA Health Claim trial
  • 60 participants
    ‍
Results:
5x
Faster trial setup than competing quotes
Therapeutic Area:
Pre-diabetes
Description:
  • Pivotal trial
  • Three-arm trial evaluating digital intervention
Results:
36x
Recruitment rate uplift
Therapeutic Area:
Psychedelics
Description:
  • Studying the effects of ketamine in healthy volunteers
  • 70 participants
Results:
100%
Enrolment in <1 year
Therapeutic Area:
Saliva Direct
Description:
  • Saliva test for COVID-19
  • Global research
    ‍
Results:
>1000
Leads in <2 months
Therapeutic Area:
Severe Insomnia
Description:
  • Site based
  • Drug trial with PK
Results:
2x
Faster start up using Citrus™ EDC study builder for rapid deployment
Therapeutic Area:
Social Anxiety
Description:
  • 200 participant fully virtual study
  • Nationwide recruitment
Results:
4x
Faster study startup than academic site
Therapeutic Area:
Tinnitus
Description:
  • Pivotal Study
  • 150 Participants
Results:
3X
Faster Recruitment via EHR record searches
Therapeutic Area:
Type 2 Diabetes
Description:
  • Prospective RCT
  • Fully decentralised
  • 100 participants
Results:
>3x
Faster than competing providers

‍

Download full case study here

Therapeutic Area:
Type II Diabetes DIGA
Description:
  • Type 2 Diabetes
  • 101 participant study
  • Supporting a DiGA listing

‍

Results:
89%
Retention rate

‍